Unilateral cataract patients perform near and distance activities more easily

Article

Patients with unilateral cataract find it easier to perform near and distance activities than bilateral patients.

Patients with unilateral cataract find it easier to perform near and distance activities than bilateral patients, reveals a study in the Journal of Paediatric Ophthalmology and Strabismus.

Dr Caitriona Kirwan et al., Children's University Hospital, University College, Dublin, Ireland, conducted a retrospective chart review on 16 patients with a history of unilateral cataract and 22 patients with bilateral cataract. Each patient previously underwent surgery when aged 24 months of younger.

Patients aged 13 years or older were selected to partake in the study and educational performance was assessed. There was also a control group of 15 healthy participants with no visual complaints. All volunteers completed a questionnaire.

The bilateral cataract group found it harder to perform near and distance activities compared to the unilateral group. The bilateral group also had significantly lower vision-specific social functioning, role difficulties, mental health, and composite scores.

However, between the unilateral and bilateral groups there was no significant difference in ocular pain, vision-specific social functioning, role difficulties and dependency scores.

Both groups were comparable with regards to general vision scores, but the unilateral cataract group found it easier to perform near and distance activities and specific vision tasks.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.